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e have used RNA interference to knock down the
AP-2 
 
 
 
2 subunit and clathrin heavy chain to un-
detectable levels in HeLaM cells. Clathrin-
coated pits associated with the plasma membrane were still
present in the AP-2–depleted cells, but they were 12-fold
less abundant than in control cells. No clathrin-coated pits
or vesicles could be detected in the clathrin-depleted cells,
and post-Golgi membrane compartments were swollen.
Receptor-mediated endocytosis of transferrin was severely
inhibited in both clathrin- and AP-2–depleted cells. Endo-
W
 
cytosis of EGF, and of an LDL receptor chimera, were also
inhibited in the clathrin-depleted cells; however, both were
internalized as efﬁciently in the AP-2–depleted cells as in
control cells. These results indicate that AP-2 is not essential
 
for clathrin-coated vesicle formation at the plasma membrane,
but that it is one of several endocytic adaptors required for
the uptake of certain cargo proteins including the transferrin
 
receptor. Uptake of the EGF and LDL receptors may be
facilitated by alternative adaptors.
 
Introduction
 
The AP-2 adaptor complex has long been assumed to be
essential for clathrin-mediated endocytosis. It is a major
component of purified clathrin-coated vesicles, second in
abundance only to clathrin itself in most coated vesicle prep-
arations. It has been shown to have binding sites not only for
clathrin, but also for cargo proteins and for phospholipids.
The prevailing view is that clathrin-mediated endocytosis is
initiated by the recruitment of AP-2 onto the plasma mem-
brane. Once on the plasma membrane, AP-2 interacts with
sorting signals in the cytoplasmic domains of membrane
proteins destined to become cargo in the coated vesicle. At
the same time, AP-2 recruits clathrin onto the membrane,
where it acts as a scaffold for vesicle budding. Recently, a
number of accessory proteins have been identified that also
participate in clathrin-mediated endocytosis, all of which
bind either directly or indirectly to subunits of the AP-2
complex. These proteins together form an interconnected
network, with AP-2 believed to be the central component
(for review see Conner and Schmid, 2003a).
Although most of the available data are consistent with
this model, there are a few discrepancies. First, the budding
yeast 
 
Saccharomyces cerevisiae
 
 has an AP-2–related complex,
AP-2R; however, deleting genes encoding AP-2R subunits
has no apparent effect on clathrin-mediated endocytosis, or
indeed, on any other pathway that has been investigated
(Yeung et al., 1999). A caveat here is that AP-2R may not be
functionally equivalent to AP-2 in higher cells. Second,
some of the accessory proteins that bind to AP-2 have prop-
erties suggesting that they may be adaptors in their own
right. Epsin, 
 
 
 
-arrestin, AP180/CALM, Hip1, Dab2, and
ARH have all been shown to bind not only to AP-2, but also
to PIP
 
2
 
 and to clathrin, indicating that they may be able to
bind to the plasma membrane and to recruit clathrin in an
AP-2–independent manner (Gaidarov et al., 1999; Ford et
al., 2001, 2002; Mishra et al., 2001, 2002a,b). There is also
some evidence that each of these proteins may interact with
a specific type of cargo. For instance, epsin has ubiquitin-
interacting motifs that may help to facilitate the internalization
of plasma membrane proteins like the EGF receptor, which
is ubiquitinated in response to ligand binding. Dab2 and
ARH are able to bind NPXY motifs, found in members of
the LDL receptor family (for review see Bonifacino and
Traub, 2003). Thus, an alternative view is that AP-2 may be
just one of several endocytic adaptors, and that although it
participates in the network of protein–protein interactions
and is required for the uptake of certain types of cargo, it is
not essential for clathrin-mediated endocytosis.
We asked the question, what would happen if AP-2 were
to drop out of the network? Would clathrin and accessory
proteins still be recruited onto the plasma membrane?
What would happen to receptor-mediated endocytosis? Us-
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ing small interfering RNAs (siRNAs), we have been able to
knock down the expression of the 
 
 
 
2 subunit of the AP-2
complex to undetectable levels in HeLaM cells. Then, we
compared the phenotype of the AP-2–depleted cells with
that of cells treated with siRNAs directed against clathrin
heavy chain.
 
Results
 
Depletion of AP-2 and clathrin by RNA interference
 
To find the most effective conditions for depleting AP-2 and
clathrin, a number of siRNAs were synthesized, and both
single and double transfections were performed. We found
that siRNAs 
 
 
 
2-2 and chc-2 (see Materials and methods),
directed against the AP-2 
 
 
 
2 subunit and clathrin heavy
chain, respectively, produced the most complete disruption,
and that in both cases it was best to transfect the cells twice,
with a 48-h interval in between. An siRNA directed against
the AP-2 
 
 
 
 subunit (
 
 
 
-2) also worked well, but not quite as
effectively as 
 
 
 
2-2 or chc-2. Fig. 1 a shows Western blots of
equal protein loadings of control and siRNA-treated cells
two days after the second transfection. The signals from both
 
 
 
2 and clathrin heavy chain are undetectable after knock-
down, whereas a weak signal (
 
 
 
5% of control) could be de-
tected in the 
 
 
 
-2–treated cells.
Although the 
 
 
 
2 and 
 
 
 
 siRNAs only directly affect the ex-
pression of the subunit against which they were targeted,
Fig. 1 b shows that levels of the other subunit were also re-
duced. In contrast, depleting AP-2 subunits has no effect on
the amount of clathrin in the cell, and clathrin depletion
does not affect the levels of AP-2 (Fig. 1 b). We also investi-
gated whether depleting 
 
 
 
2 affects the proportion of soluble
versus membrane-associated 
 
 
 
, by centrifuging cell homoge-
nates at high speed and then probing Western blots of the
supernatant and pellet. Fig. 1 c shows that normally, most of
the 
 
 
 
 is in the pellet, but depleting 
 
 
 
2 causes some of the
protein to shift into the supernatant. These results are con-
sistent with analyses of the AP-1 and AP-3 complexes, which
show that deleting any one of the subunits decreases the sta-
bility of the remaining subunits, and that the partial com-
plexes that form in the absence of a particular subunit are in-
active and fail to localize to membranes (Meyer et al., 2000;
Peden et al., 2002).
Both AP-2 and clathrin depletion were found to slow
down the growth of the cells, but we did not see any appar-
ent increase in apoptosis (unpublished data), although clath-
rin loss has been reported to cause apoptosis in a chicken B
cell line (Wettey et al., 2002). By phase-contrast micros-
copy, the 
 
 
 
2-2–treated cells look essentially normal (com-
pare Fig. 1 e with the control cells in Fig. 1 d). However,
many of the chc-2–treated cells were found to be heavily
vacuolated, and nearly half of the cells had two or more nu-
clei (Fig. 1 f), indicating that cytokinesis is blocked in clath-
rin-depleted cells. Interestingly, a similar phenotype has been
reported in clathrin-deficient 
 
Dictyostelium
 
 (Niswonger and
O’Halloran, 1997).
Fig. 1 (g–n) shows the appearance of the cells by immuno-
fluorescence. In g–k, either control cells (g) or AP-2 knock-
down cells (h–k) were labeled with an antibody against the
AP-2 
 
 
 
 subunit. After a single transfection, the 
 
 
 
-adaptin la-
beling was found to be very patchy in both 
 
 
 
-2–treated (h)
and 
 
 
 
2-2–treated (i) cells; individual spots were of approxi-
mately equal intensity to those in control cells, but much
fewer in number and usually occurring in clusters. After two
transfections (j and k), membrane-associated labeling was es-
sentially undetectable in the 
 
 
 
2-2–treated cells, although cy-
tosolic labeling of partial complexes containing the 
 
 
 
 subunit
could be seen (k). The 
 
 
 
-2 knockdown (j) was not quite so
complete in that some of the cells still had residual spots after
the second transfection. Clathrin knockdowns (l–n) caused a
more uniform loss of signal. After a single transfection (m),
the number of clathrin-positive spots per cell was similar to
controls (l), but the intensity of the spots was reduced. After
two transfections, clathrin labeling was essentially undetect-
able (n). In all three cases, virtually 100% of the cells were af-
fected by the end of the full course of treatment.
 
Localization of other proteins 
in the siRNA-treated cells
 
To find out what happens to other coat proteins in cells
where one of them has been depleted, we performed triple
labeling on cells treated with both 
 
 
 
2-2 and chc-2 siRNAs.
For these experiments, we plated out equal numbers of con-
trol and siRNA-treated cells onto microscope slides so the
two types of cells could be viewed together in the same field,
and then labeled the cells with antibodies against 
 
 
 
-adaptin
(blue), clathrin heavy chain (red), and epsin 1 (green).
Fig. 2 shows that normally, the three proteins have overlap-
ping distributions at the plasma membrane, with additional
intracellular structures labeled with the clathrin antibody.
Knocking down 
 
 
 
2 causes a reduction in the number of epsin
spots (c). These spots do not contain any detectable 
 
 
 
-adaptin,
which is now diffuse and cytosolic (a). However, many of the
epsin-positive spots in these cells are also positive for clathrin
(b; insets), suggesting that the two proteins are able to co-assem-
ble on the plasma membrane even in the absence of AP-2.
In cells where clathrin had been depleted, AP-2 labeling was
not markedly different from control cells (d). There were still
multiple spots associated with the plasma membrane, often
occurring in rows. These spots were also positive for epsin (f).
However, the epsin labeling was consistently brighter in clath-
rin-depleted cells, indicating that more of the protein was as-
sociated with the plasma membrane. This was confirmed by
Western blotting of cell homogenates centrifuged at high
speed; in control and AP-2–depleted cells, epsin partitioned
approximately equally between supernatant and pellet, whereas
in clathrin-depleted cells, it was found almost exclusively in
the pellet (unpublished data).
 
Ultrastructure of the cells
 
To observe the phenotype of AP-2– and clathrin-depleted
cells at the ultrastructural level, EM was performed. Fig. 3 (a
and b) shows that control cells contain numerous clathrin-
coated pits associated with the plasma membrane, indicated
with the large arrowheads. A morphometric analysis (Fig. 4)
showed that in these cells, 0.6% of the cell surface is occu-
pied by clathrin-coated pits. In the AP-2–depleted cells
(c–e), clathrin-coated pits were found to be 12-fold less
abundant, occupying only 0.05% of the cell surface. The
morphology of the coat appears to be identical in controlT
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Figure 1. Effects of depleting AP-2 and clathrin heavy chain from HeLaM cells. (a) Equal protein loadings of homogenates of either control 
cells or cells treated with siRNAs directed against clathrin heavy chain,  -adaptin, or  2 were subjected to SDS-PAGE, and Western blots were 
probed with antibodies against the indicated protein. Clathrin heavy chain and the AP-2  2 subunit were both undetectable after knockdown, 
whereas a weak signal ( 5% of control) was detected after   knockdown. (b) Equal protein loadings of homogenates from control and siRNA-
treated cells were subjected to SDS-PAGE, and Western blots were cut in four and probed with the indicated antibody. Anti-actin was included 
as a loading control. As well as affecting its target, the   siRNA causes a depletion in  2, and the  2 siRNA causes a depletion in  . (c) Homogenates 
of control and  2-depleted cells were centrifuged at high speed, and supernatants and pellets were probed with anti- . Knocking down  2 
increases the percentage of   in the supernatant. (d–f) Phase-contrast micrographs of cells treated with a control (nonfunctional) siRNA (d), cells 
treated with  2 siRNA (e), and cells treated with clathrin heavy chain siRNA (f). The  2 siRNA-treated cells look essentially normal. However, 
many of the clathrin heavy chain siRNA-treated cells are vacuolated, and nearly half are multinucleated. (g–k) Control cells (g), cells treated once 
with   (h) and  2 (i) siRNAs, and cells treated twice with   (j) and  2 (k) siRNAs were labeled with an antibody against the AP-2   subunit. The 
labeling becomes patchy after one hit, and after both hits there is little or no label associated with the plasma membrane. (l–n) Control cells (l) 
and cells treated once (m) or twice (n) with a clathrin heavy chain siRNA were labeled with an antibody against clathrin. The signal disappears 
more uniformly than the AP-2 signal, again becoming undetectable on membranes after two hits. Bars, 20  m.T
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and AP-2–depleted cells; however, the coated pits tend to be
smaller in the AP-2–depleted cells. In the clathrin-depleted
cells, clathrin-coated pits were undetectable, and nearly all of
the budding profiles that could be observed at the plasma
membrane had the characteristic appearance of caveolae.
We also examined intracellular membranes in the control
and knockdown cells. Fig. 3 f shows the Golgi region of an
AP-2–depleted cell, with the Golgi stack indicated (G). A
clathrin-coated vesicle (arrow) can be seen budding from a
membrane on the trans side of the stack, presumably the
TGN. Control cells have a similar Golgi morphology (un-
published data). However, in clathrin-depleted cells, there is
a striking amount of swelling of post-Golgi compartments
(Fig. 3 g), presumably because membrane is unable to leave
by the clathrin-coated vesicle route.
 
Effects on clathrin-mediated endocytosis: 
transferrin receptor
 
It has been well documented that AP-2 is required for the up-
take of cargo proteins with YXX
 
 
 
-type sorting signals, such as
Figure 2. Immunofluorescence triple labeling of control and siRNA-treated cells plated together. (a–c and g). Cells treated with  2-2 and 
control cells were labeled with mouse anti- -adaptin (a; blue in g), rabbit anti-clathrin (b; red in g), and goat anti-epsin 1 (c; green in g). 
 -Adaptin is cytosolic in the  2-depleted cells. Clathrin is still membrane-associated; however, many of these membranes are intracellular. 
Epsin spots are reduced in number, but are still present in the  2-depleted cells. Many of these spots are also positive for clathrin. The two 
boxed-in regions are shown at higher magnification in the bottom right corner of all the panels in a–c. (d–f and h) Cells treated with chc-2 
and control cells were labeled with mouse anti- -adaptin (d; blue in h), rabbit anti-clathrin (e; red in h), and goat anti-epsin (f; green in h). 
Clathrin is undetectable in the siRNA-treated cells.  -Adaptin labeling is not markedly different; however, epsin labeling is brighter in the 
clathrin-depleted cells. Bars, 20  m.T
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the transferrin receptor. This motif has been shown to bind to
hydrophobic pockets in the 
 
 
 
2 subunit (Ohno et al., 1995;
Owen and Evans, 1998). Mutating the signal in the transferrin
receptor prevents the receptor from entering the cell by clath-
rin-mediated endocytosis, causing it to be internalized 5–10
times more slowly (Jing et al., 1990). Similarly, mutating the
 
 
 
2 subunit so that it can no longer bind the motif, and then
overexpressing it in cells so that most of the AP-2 complexes
contain mutant rather than wild-type 
 
 
 
2, also strongly inhib-
its uptake of the transferrin receptor (Nesterov et al., 1999).
Fig. 5 a shows the effects of AP-2 and clathrin knockdown
on transferrin receptor endocytosis. For these experiments,
the cells were incubated at 4
 
 
 
C with 
 
125
 
I-labeled transferrin
to allow binding (but not internalization) to occur, and then
were warmed to 37
 
 
 
C for various lengths of time. At the end
of the incubation, the medium was harvested, surface-bound
ligand was stripped off at low pH, the cells were solubilized
in 1 M NaOH, and the label in all three fractions was quan-
tified. The percentage of counts in the NaOH extract (i.e.,
intracellular counts) is shown in the graph. In control cells,
 
 
 
50% of the prebound transferrin is internalized within 5
min after warm-up, but after 10 min, the amount of intra-
cellular transferrin starts to go down, as it gets recycled back
into the medium. Knocking down both AP-2 and clathrin
Figure 3. Electron micrographs of 
control and siRNA-treated cells. 
The cells in these experiments were 
incubated with an antibody against the 
transferrin receptor coupled to 8-nm 
gold before fixation to monitor the effi-
ciency of transferrin receptor endocytosis. 
(a and b) Control cells have abundant 
clathrin-coated pits (large arrowheads) 
associated with the plasma membrane. 
Gold particles (small arrowheads) can 
be seen in endosomes. (c–f) Cells were 
treated with  2-2 siRNA. These cells still 
have clathrin-coated pits associated with 
the plasma membrane, but when the pits 
were quantified by morphometry in 
control and AP-2–depleted cells, they 
were found to be 12-fold less abundant 
in the AP-2–depleted cells. Morpho-
logically, the coated pits are similar to 
those in control cells, but they tend to 
be smaller. Gold particles (small arrow-
heads) remain on the cell surface. A 
clathrin-coated bud or vesicle in the 
Golgi region (G) is indicated with the 
arrow in f. (g) Clathrin-depleted cells 
have no recognizable clathrin-coated 
pits or vesicles, either at the plasma 
membrane or on intracellular membranes, 
although COP-coated vesicles can still 
be seen on the cis side of the Golgi 
stack. In addition, membranes 
on the trans side of the Golgi stack are 
swollen. Bar, 500 nm.T
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causes a profound inhibition of transferrin uptake. In both
cases, the transferrin never accumulates inside the cells, but
remains primarily on the cell surface, where it slowly dissoci-
ates into the medium. Even after 30 min, 
 
 
 
10% of the
transferrin is recovered in the intracellular fraction. Thus, as
expected, both AP-2 and clathrin are required for efficient
internalization of the transferrin receptor.
 
EGF receptor
 
The behavior of the EGF receptor was less predictable. This
receptor has a YXX
 
 
 
 consensus sequence in its cytoplasmic
tail, which binds to 
 
 
 
2 in vitro (Owen and Evans, 1998),
and which acts as an internalization signal when trans-
planted onto other proteins (Chang et al., 1993). Surpris-
ingly, however, mutating this sequence does not change the
internalization rate of the receptor (Nesterov et al., 1995;
Sorkin et al., 1996). In addition, EGF receptor endocytosis
was found to proceed normally in cells expressing mutant
 
 
 
2 (Nesterov et al., 1999). These observations indicate that
the receptor must have another signal (or signals) for en-
docytosis, and there is increasing evidence that ubiquitin
may be that signal (Haglund et al., 2003). However, it has
not yet been tested whether EGF internalization is really in-
dependent of AP-2, because the cells expressing mutant 
 
 
 
2
still contained normal levels of AP-2, which was recruited
normally onto the plasma membrane (Nesterov et al., 1999).
Thus, it is possible that the EGF receptor may bind to an-
other part of AP-2, and/or that AP-2 may be necessary for
coat assembly.
Fig. 5 b shows a similar experiment to the one shown in
Fig. 5 a, but using 
 
125
 
I-labeled EGF as the ligand. In control
cells, EGF is internalized slightly more slowly than transfer-
rin, but by 10 min, 
 
 
 
50% of the label is intracellular.
Figure 4. Morphometric analysis of the EM data, using 128 images 
of each condition. For the control cells, 7,630 plasma membrane 
intersections were scored, of which 45 were coated pit intersections 
(0.6%). For the  2-2–treated cells, 11,361 plasma membrane 
intersections were scored, of which six were coated pit intersections 
(0.05%). For the chc-2–treated cells, 7,585 plasma membrane inter-
sections were scored, of which none were coated pit intersections.
Figure 5. Kinetics of ligand uptake in control and siRNA-treated 
cells. (a) Cells were allowed to bind 
125I-labeled transferrin at 4 C, 
and were then shifted to 37 C for the indicated length of time, 
after which the medium was harvested, ligand remaining on 
the cell surface was released with an acid wash, the cells were 
solubilized with NaOH, and all three fractions were quantified 
and expressed as a percentage of total counts/m. The graph shows 
percentage of total counts recovered in the NaOH extract (i.e., 
internalized transferrin). Each point is derived from at least three 
separate experiments; the error bars show the SEM. Both  2- and 
clathrin-depleted cells are strongly impaired in their ability to 
internalize transferrin. (b) Cells were treated exactly as in a, but 
using 
125I-labeled EGF. Uptake is strongly inhibited in the clathrin-
depleted cells, but it is not significantly different from control in 
the  2-depleted cells. (c) Cells expressing a chimera consisting 
of the CD8 extracellular and lumenal domains fused to the LDL
receptor cytoplasmic tail were incubated at 4 C with an mAb 
against CD8 followed by 
125I-labeled protein A, and were then 
shifted to 37 C and treated as in a and b. Again, uptake is strongly 
inhibited in the clathrin-depleted cells, but similar to controls in 
the  2-depleted cells. Virtually identical results were obtained 
using  -depleted cells, except that the effect on transferrin uptake 
was not quite so profound, presumably because the knockdown 
was less complete (not depicted).T
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Knocking down clathrin strongly inhibits the receptor-me-
diated endocytosis of EGF. Strikingly, however, knocking
down AP-2 has no significant effect on EGF uptake. The
rate of accumulation of intracellular EGF is virtually identi-
cal in control and AP-2–depleted cells.
 
LDL receptor
 
There is currently some controversy as to how the LDL re-
ceptor’s internalization signal actually works. This signal has
been reported to bind to several coat components, including
the 
 
 
 
2 subunit of AP-2 (Boll et al., 2002), clathrin (Kibbey
et al., 1998), and proteins with phosphotyrosine-binding
domains like Dab2 and ARH (Mishra et al., 2002a,b). Ini-
tially, we attempted to monitor receptor internalization us-
ing 
 
125
 
I-labeled LDL, but these experiments were compli-
cated by the very rapid dissociation of the ligand from its
receptor in HeLa cells (see Materials and methods). There-
fore, we stably transfected the cells with a construct consist-
ing of the extracellular and transmembrane domains of CD8
fused to the LDL receptor tail, then assayed for internaliza-
tion following a similar protocol to the one just mentioned,
but with anti-CD8 followed by 
 
125
 
I-labeled protein A as the
ligand. Fig. 5 c shows that in control cells, the LDL receptor
chimera is efficiently internalized, and that knocking down
clathrin strongly inhibits uptake. However, knocking down
AP-2 again has no effect on the rate of endocytosis of the
protein. Thus, out of the three transmembrane proteins that
we have analyzed in siRNA-treated HeLa cells, two are inter-
nalized in an AP-2–independent manner.
 
Discussion
 
In this work, we have knocked down both clathrin heavy
chain and the AP-2 
 
 
 
2 subunit to undetectable levels using
siRNAs. Remarkably, we find that clathrin-mediated en-
docytosis can still occur in the absence of any detectable AP-2
at the plasma membrane. Although we cannot rule out the
possibility that trace amounts of AP-2 may contribute to en-
docytosis in the siRNA-treated cells, it is clear that AP-2 is
not an essential structural component of the coat, as had al-
ways been assumed. A similar conclusion has been reached
by Conner and Schmid (2003b, in this issue), who used a
different approach to inactivate AP-2, and also found that
effects on clathrin-mediated endocytosis were cargo-specific.
This means that there must be other proteins in the cell that
can fulfill the role that had always been assigned to AP-2.
These proteins cannot completely replace AP-2, because the
number of coated pits per cell is reduced by 12-fold in
AP-2–depleted cells, and clathrin-mediated endocytosis of
the transferrin receptor is abolished. In addition, others have
shown that mutations in the AP-2   subunit in Drosophila
cause either embryonic lethality or neurological defects, de-
pending on the allele (Gonzalez-Gaitan and Jackle, 1997).
However, we find that both the EGF receptor and the
LDL receptor chimera are internalized just as efficiently in
AP-2–depleted cells as in control cells, presumably by mak-
ing use of alternative adaptors.
Over the last several years, a number of reports have been
published that challenge the view that all cargo proteins are
endocytosed by the same molecular mechanism. Marks et al.
(1996) showed that overexpression of constructs with either
YXX  or dileucine internalization signals causes endoge-
nous proteins with the same signal to accumulate on the cell
surface, but endogenous proteins with the other signal are
still endocytosed normally. They concluded that the two sig-
nals were competing for two distinct components of the en-
docytic machinery. However, they could not rule out the
possibility that both of these components were part of the
AP-2 complex, and indeed, subsequent reports showed that
dileucine signals can also bind to AP complexes, most likely
through their   subunits (for review see Bonifacino and
Traub, 2003). Warren et al. (1998) used a similar approach
to show that the transferrin, EGF, and LDL receptors do
not compete with each other for internalization. They sug-
gested that although AP-2 interactions might be necessary
for the internalization of some cargo proteins, other cargo
proteins could be interacting with other components of the
coat. However, until now, it has not been possible to test
these ideas by specifically depleting different coat compo-
nents from the cell.
The approach that we have used in the present paper
should be widely applicable for looking at the internalization
of other transmembrane proteins, to determine whether or
not their endocytosis is dependent on AP-2. So far, most
functional analyses of the roles of various proteins in clath-
rin-mediated endocytosis have made use of dominant-nega-
tive mutants (for review see Conner and Schmid, 2003a),
but these may lead to indirect effects (e.g., overexpressing a
truncated version of a particular protein may impede inter-
actions involving other components of the coated pit). RNA
interference is a much cleaner way of testing the function of
a protein because it removes the protein instead of altering it
and adding it back in excess amounts. The CD8 chimera
system may be especially useful, because theoretically, one
could transplant the cytoplasmic tail from any type I mem-
brane protein, or an artificial tail designed to test a potential
internalization signal, onto the CD8 reporter, and then assay
for uptake using reagents that are commercially available.
Fig. 6 is a schematic diagram summarizing our results and
how we interpret them. Normally, clathrin, AP-2, and alter-
native adaptors all co-assemble at the plasma membrane,
bringing cargo with different types of internalization signals
into the coated pit. In the absence of AP-2, alternative adap-
tors are still recruited onto the plasma membrane, where
they interact with a subset of the cargo proteins, including
the EGF and LDL receptors, and co-assemble with clathrin.
These cargo proteins are still efficiently internalized, but
cargo proteins like the transferrin receptor, which can only
interact with AP-2, stay on the cell surface. In addition, be-
cause AP-2 is the major clathrin adaptor at the plasma mem-
brane, there is less clathrin recruited onto the membrane and
fewer (and perhaps smaller) coated pits per cell. In the ab-
sence of clathrin, both AP-2 and alternative adaptors are still
recruited onto the plasma membrane, where they interact
with each other and most likely with potential cargo pro-
teins as well, but there are no morphologically recognizable
coated pits, and all of the cargo proteins are internalized
much more slowly.
Several recent papers provide insights into the identity of
these alternative adaptors. In particular, Traub and col-T
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leagues have shown that a number of the endocytic accessory
proteins, including epsin, Hip1, Dab2, and ARH, can bind
to plasma membrane lipids and to clathrin, and they have
proposed that these proteins may, in fact, be cargo-selective
clathrin adaptors (Mishra et al., 2001, 2002a,b). However,
they hypothesize that the role of these proteins is to “poten-
tiate AP-2–driven coat formation” (Mishra et al., 2002a),
whereas the present paper suggests that alternative adaptors
may, in fact, be just as capable of driving coat formation as
AP-2. This makes mammalian cells much more similar to
yeast in this regard than had previously been suspected. S.
cerevisiae can still carry out most of its clathrin-mediated
trafficking even when all three of its AP complexes are ab-
sent (Huang et al., 1999; Yeung et al., 1999), presumably
because most of its cargo proteins do not depend on YXX 
motifs. Ubiquitin appears to be the major endocytic signal
in yeast, and there is some evidence that it is recognized by
the epsin orthologues Ent1p and Ent2p (Shih et al., 2002;
Aguilar et al., 2003). Mammalian epsins may play a similar
role, capturing ubiquitinated cargo proteins like the acti-
vated EGF receptor. ARH and Dab2 are both good candi-
dates for cargo-specific adaptors for the LDL receptor, and
may be functionally redundant because mutations in either
gene alone do not block LDL uptake (Mishra et al., 2002b).
By using RNA interference to deplete these and other candi-
date adaptors from cells (either alone or in combination)
and then monitoring the internalization of different mem-
brane proteins, it should be possible to match each of the al-
ternative adaptors with its respective cargo.
Materials and methods
siRNA knockdowns
HeLaM cells (Tiwari et al., 1987) were seeded at a density of 10
6 cells per
9-cm dish. At least 2 h after seeding the cells, the first transfection was per-
formed. For each 9-cm dish, 50  l OligofectAMINE™ (Invitrogen) was
added to 100  l Opti-MEM
® I (Life Technologies), and the solution was in-
cubated at RT for 5–10 min. This was then added to a second solution or
800  l Opti-MEM
® I plus 50  l 20  M siRNA, and the mixture was incu-
bated at RT for 15–20 min. Next, 4 ml Opti-MEM
® I was added to the
siRNA mixture to make a final volume of 5 ml, and this was added to the
cells after rinsing them once with Opti-MEM
® I. The transfection mixture
was left for 4 h on the cells, after which 5 ml DME containing 20% FCS
without antibiotics was added, and the cells were left in this mixture until
they were trypsinized the following day. Two transfections were per-
formed, on d 0 and d 2. The cells were trypsinized 24 h after each transfec-
tion and were seeded into two 9-cm dishes for the second transfection,
whereas after the second transfection, they were plated onto coverslips or
35-mm dishes for uptake assays. For each experiment, an extra 35-mm
dish was used to assay efficiency of knockdown.
Two independent siRNAs were used to investigate the effects of knock-
down of each target. For AP-2, the targets were the   and  2 subunits of
the complex. The  -2 siRNA target sequence was AAGAGCAUGUG-
CACGCUGGCCA and the  2-2 target sequence was AAGUGGAUGCCU-
UUCGGGUCA (other sequences, designated  -1 and  2–1, were in-
effective). The clathrin heavy chain target sequences were AAG-
CUGGGAAAACUCUUCAGA (chc-1) and UAAUCCAAUUCGAAGAC-
CAAU (chc-2). The control siRNA was a nonfunctional oligo,  2–1, origi-
nally designed to knock down the  2 subunit, target sequence AACACAG-
CAACCUCUACUUGG. All siRNAs were designed according to the
manufacturer’s instructions and were synthesized as Option C siRNAs by
Dharmacon, Inc.
Immunofluorescence and Western blotting
Antibodies used for immunofluorescence included an affinity-purified
rabbit polyclonal antiserum directed against clathrin heavy chain (Simp-
son et al., 1996); a mouse monoclonal anti- -adaptin, AP.6, provided by
Frances Brodsky (University of California, San Francisco, San Francisco,
CA); and a commercially available goat anti-epsin 1 (Santa Cruz Biotech-
nology, Inc.). Secondary antibodies were all purchased from Molecular
Probes, Inc. For Western blotting,   and  2 subunits of AP-2 were de-
tected using mouse monoclonal antibodies from Transduction Laborato-
ries, clathrin heavy chain was detected using the same rabbit antibody
that was used for immunofluorescence, and actin was detected using a
rabbit antibody from Sigma-Aldrich. Incubations with the mouse anti-
bodies were followed by an incubation with rabbit anti–mouse immuno-
globulin (DakoCytomation). The blots were then probed with 
125I-labeled
protein A (Amersham Biosciences).
EM
Cells to be used for EM were first fed with mouse anti-transferrin receptor
B3/25 conjugated to 8-nm gold, a gift from Colin Hopkins and Liz Alichin
(Imperial College London, London, UK). The cells were incubated with the
antibody–gold conjugate for 30 min at 4 C, followed by a 10-min chase at
37 C. They were then fixed in tissue culture dishes by adding double-
strength fixative (5% glutaraldehyde and 4% PFA in 0.2 M sodium cacody-
late, pH 7.2, containing 6 mM CaCl2) to an equal volume of tissue culture
Figure 6. Model showing interactions at the plasma membrane in 
control and siRNA-treated cells. In control cells, AP-2 and alternative 
adaptors are both recruited onto the plasma membrane, where they 
interact with each other and recruit clathrin through interactions 
mainly involving their flexible linker and appendage domains, 
whereas their more highly structured domains interact with phos-
phoinositides and with cargo. In AP-2–depleted cells, only alternative 
adaptors are recruited onto the plasma membrane, but these can 
still associate with each other (e.g., through EH domain–NPF inter-
actions and SH3 domain–proline-rich domain interactions), and 
can still recruit clathrin and bring a subset of cargo proteins into 
the coated pit. However, without AP-2 there is less clathrin on the 
plasma membrane and fewer coated pits per cell, and cargo proteins 
that only have signals for AP-2 do not get internalized into coated 
vesicles. In clathrin-depleted cells, AP-2 and alternative adaptors 
are both recruited onto the plasma membrane, where they interact 
with each other and with cargo, but the membrane does not invagi-
nate and there is no selective uptake of cargo.T
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medium for 2 min at 37 C. This solution was aspirated off and replaced by
2.5% glutaraldehyde and 2% PFA in 0.1 M sodium cacodylate buffer, pH
7.2, containing 3 mM CaCl2. The cells were fixed for a further 3 h at RT,
washed with 0.1 M sodium cacodylate buffer, pH 7.2, and post-fixed with
1% osmium tetroxide in 0.1 M sodium cacodylate buffer, pH 7.2, for 1 h.
The cells were scraped from the dish and pelleted, and the pellet was
washed with 0.05 M sodium maleate buffer, pH 5.2, and en bloc stained
with 0.5% uranyl acetate in 0.05 M sodium maleate buffer. The cell pellets
were dehydrated in ethanol, exchanged into 1,2-epoxy propane, and em-
bedded in Araldite CY212 epoxy resin (Agar Scientific).
50-nm ultrathin sections were cut using a diamond knife mounted on
an ultramicrotome (Reichert Ultracut S; Leica), collected onto formvar/
carbon-coated EM grids, and stained with uranyl acetate and Reynolds
lead citrate (Reynolds, 1963). The sections were observed in a transmis-
sion electron microscope (model CM 100; Philips) at an operating volt-
age of 80 kV.
For quantification of the percentage of plasma membrane occupied by
coated pits, cell pellets were randomly sectioned and oriented in the elec-
tron microscope. Grids were systematically scanned at a magnification of
13,500, and 128 images of each condition were captured using a camera
(Megaview II TEM; Soft Imaging System). A 500-nm lattice overlay was used
to score intersections with the plasma membrane and coated pits (Weibel,
1979; Griffiths, 1993) using analySIS
® 3.0 image analytical software.
Internalization assays
Ligand uptake assays were performed on cells seeded onto 35-mm dishes
on the day preceding the experiment. On the day of the experiment, the
dishes were placed on ice and were washed briefly with prechilled se-
rum-free medium (SFM; DME and 20 mM Hepes containing 1% BSA).
The cells were then incubated on a rocker for 30 min at 4 C in 0.6 ml
SFM containing either 
125I-labeled EGF or 
125I-labeled transferrin (both
obtained from PerkinElmer) at a concentration of 500 nCi/ml. The dishes
were washed six times with ice-cold SFM, and the surface counts were
collected for the zero time point by incubating the cells for 5 min at 4 C
in 0.8 ml ice-cold acid wash (0.2 M acetic acid and 0.5 M NaCl), fol-
lowed by a brief rinse with another 0.8-ml acid wash. The other dishes
were incubated with 1.5 ml prewarmed medium (DME containing 10%
FCS) at 37 C for various times. Endocytosis was stopped by placing the
cells on ice, collecting the medium, and rinsing the cells with ice-cold
SFM. Label associated with the cell surface was then collected by acid
wash, as above. Finally, the intracellular fraction was collected by ex-
tracting the cells twice with 0.8 ml 1 M NaOH. The radioactivity in the
medium, acid wash, and NaOH extract was quantified using a gamma
counter (Nuclear Enterprises).
We also attempted to follow the fate of 
125I-labeled LDL, but found that
 50% of the prebound ligand dissociated within the first few minutes of
warm-up. Therefore, we made use of HeLaM cells expressing a chimera of
the extracellular and transmembrane domain of CD8 fused to the tail do-
main of the LDL receptor. Human CD8 cDNA in pBlueScript
® was a gift
from Gudrun Ihrke (University of Cambridge, Cambridge, UK; Ihrke et al.,
2001). The cytoplasmic tail of the mouse LDL receptor (from the arginine
residue at position 813) was amplified by PCR from an EST (Clone ID
2581960; GenBank/EMBL/DDBJ accession no. gi6519196) obtained from
the I.M.A.G.E. Consortium, incorporating an AflII site into the 5  end. The
resulting fragment was ligated to the AflII site at the end of the transmem-
brane domain coding sequence of CD8, and the chimera was cloned into
pIRES2Neo (CLONTECH Laboratories, Inc.). The construct was sequenced
to confirm that a correct in-frame fusion had been achieved, and was then
transfected into HeLaM cells. Stably transfected cells were selected and
maintained in the presence of 500  g/ml G418 (GIBCO BRL).
To monitor uptake of the chimera, the cells were treated as above, but
incubated with SFM containing 1:100 diluted anti-CD8 (153–020; Ancell
Corp.) instead of with a radiolabeled ligand, and the incubation was for 45
min at 4 C instead of for 30 min. The cells were then washed and incu-
bated for a further 45 min at 4 C with SFM containing 
125I-labeled protein
A (1:1,000 diluted; Amersham Biosciences). The rest of the experiment
was performed exactly as above.
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